present study investigate different activator cll cell affect cytotoxicity venetoclax particular focus cytoprotective antiapoptotic property ifnγ shed light importance immunoproteasome p38 mapk ifnγmediated druginduced resistance cll cell venetoclax potential target immunoproteasome p38 mapk successfully overcome resistance venetoclax cat n° hy15531 birb796 doramapimod hy10320 sb203580 hy10256 m3258 hy111790 ml604440 hy114170 marizomib hy10985 dithiothreitol hy15917 dtt onx0914 hy13207 quinolinevalaspdifluorophenoxymethylketone qvdoph hy12305 adenosine 5'triphosphate hyb2176 atp medchemexpress monmouth junction nj usa 4',6diamidino2phenylindole dapi 14285 valinomycin cayman chemical ann arbor mi usa ifnγ cat n° if002 phorbol 12myristate 13acetate pma p8139 ionomycin calcium salt i0634s sigmaaldrich st. louis mo usa recombinant human scd40 ligand scd40l 31002 peprotech london uk mec1 cell deutsche sammlung von mikroorganismen und zellkulturen gmbh braunschweig germany maintain iscove 's modify dulbecco 's medium gibco grand island ny usa supplement 10 heatinactivated fetal bovine serum 100 uml penicillin 100 08gml streptomycin mec1 ver cell establish culture mec1 cell presence venetoclax 3 month selection process cell maintain iscove 's modify dulbecco 's medium supplement 10 heatinactivated fetal bovine serum 100 uml penicillin 100 08gml streptomycin 100 μgml normocin invivogen san diego ca usa prevent contamination mycoplasma mec1 mec1 ver cell passaged every 23 day maintain 0.52.0 × 10 cellsml sustain resistance 10 08m venetoclax add cell culture every passage prior experiment mec1 ver cell wash phosphatebuffered saline pb resuspend venetoclaxfree normocinfree fresh culture medium primary cll cell maintain 12 × 10 cellsml roswell park memorial institute 1640 medium cat n° r5886 sigmaaldrich st. louis mo usa supplement 10 heatinactivated fetal bovine serum 2 mm lglutamine 100 uml penicillin 100 08gml streptomycin cell line test mycoplasma contamination use mycoplasmacheck qpcr test eurofins genomics ebersberg germany clinical study include 24 patient immunophenotypically confirm diagnosis cll 15 male 9 female time sample collection one patient undergo treatment venetoclax clinical characteristic patient summarize table 1. patientderived cll cell isolate 5 ml blood obtain cll patient negatively select bcells rosettesep human bcell enrichment cocktail stemcell technology serumwerk bernburg ag germany briefly 5 ml whole blood centrifuge 400× g 10 min 23 ml plasma freeze 80 °c amount plasma remove substitute equal amount 2 heatinactivated fetal bovine serumpbs sample mix well 100 08l rosettesep human bcell enrichment cocktail add follow incubation room temperature 20 min sample dilute 5 ml 2 heatinactivated fetal bovine serumpbs carefully layer 5 ml density gradient medium ficoll paque plus sigmaaldrich st. louis mo usa follow centrifugation 200× g 20 min brake bcells harvest use pipette wash 10 ml culture medium need remain erythrocyte lysed 5 ml red blood cell lysis buffer 8.02 mgml nhcl 0.84 mgml nahco 0.37 mgml 2,2',2,2'ethane1,2diyldinitrilotetraacetic acid ph 7.4. purity isolate cll cell determine use flow cytometer attune nxt invitrogen carlsbad ca usa anticd19pe antibody cat n° 302208 biolegend san diego ca usa mean ±sd cd19positivity 94.2 ±4.3 primary cll cell poor viability isolationthawing exclude study prestoblue assay fluorimetric assay measure reduction blue resazurin pink highly fluorescent resorufin mitochondrion cell thus use ass metabolic activity cell assay carry describe previously 40. briefly mec1 cell 3 × 10 cellsml primary cll cell 1 × 10 cellsml leave untreated control treat 0.1 dmso vehicle control indicate compound 100 08l cell suspension seed per well black 96well plate incubate indicate period 37 °c 5 co humidify atmosphere 10 08l prestoblue reagent invitrogen carlsbad ca usa add well plate incubate 37 °c 13 h. fluorescence intensity resorufin measure use microplate reader synergy htx multimode microplate reader biotek instrument inc. winooski vt usa excitationemission filter 530590 nm relative metabolic activity calculate ii × 100 data mean ± sem ≥three independent experiment carry duplicate mec1 mec1 ver cell 3 × 10 cellsml treat 0.1 dmso vehicle control 150 08m venetoclax 100 08l cell suspension add duplicate well 96 well plate incubate indicate period 37 °c 5 co humidify atmosphere 5 08m propidium iodide pi molecular probe eugene usa add incubate 5 min gentle shake plate afterward minimum 10,000 event collect use autosampler connect flow cytometer attune nxt invitrogen carlsbad ca usa data mean ± sem three independent experiment carry duplicate detection early apoptosis sytox blueannexin v assay carry describe previously 40. briefly cll cell 1 × 10 cellsml mec1 cell 3 × 10 cellsml treat 0.1 dmso compound interest 24 h harvest determination phosphatidylserine exposure use rphycoerythrin conjugate annexin v rpe annexin v invitrogen carlsbad ca usa membrane integrity use nucleic acid stain sytox blue dead cell stain invitrogen carlsbad ca usa cell wash 0.3 ml icecold pb resuspend annexinbinding buffer 1 × 10 cellsml 100 08l sample 2.5 08l annexin v add incubate dark 15 min 200 08l annexinbinding buffer sytox blue add final concentration 750 nm minimum 10,000 event per sample collect use autosampler connect flow cytometer attune nxt invitrogen carlsbad ca usa experiment repeat three time representative dot plot show cell stain double negative annexin v sytox blue anvsb undergo measurable apoptosis thus consider viable conversely cell stain doublepositive annexin v sytox blue anv sb consider lateapoptotic dead cell stain positive annexin v anv sb undergo early apoptosis stain positive sytox blue consider necrotic data mean ± sem three independent experiment mitochondrial membrane potential δψm determine use mitoprobe jc1 assay kit invitrogen carlsbad ca usa mec1 cell 3 × 10 cellsml treat 0.1 dmso 100 nm 250 nm 500 nm onx0914 24 h. positive control cell treat 1 08m valinomycin 1 h. cell pelleted 200× g 5 min resuspend 300 08l pb 2 08m jc1 incubate dark 20 min wash 1 ml pb 200× g 5 min cell resuspend 500 08l pb intensity red high δψm green low δψm fluorescence jc1 determine use flow cytometry minimum 10,000 event collect use flow cytometer attune nxt invitrogen carlsbad ca usa data mean ± sem three independent experiment patientderived cll cell 2 × 10 cellsml seed 12 well plate incubate 0.1 dmso 100 ngml ifnγ 10 nm pma 1 08m ionomycin 100 ngml scd40l 1 h 37 °c 5 co humidify atmosphere sample centrifuge 300× g 5 min supernatant discard cell fix 200 08l 4 paraformaldehyde 10 min pb 1.4 ml add sample vortexed centrifuge 300× g 5 min cell resuspend 100 08l nfκb p65 d14e12 xp rabbit mab 8242 cell signal technology danvers usa prepare 1:1,000 dilution 0.1 triton x1005 bovine serum albuminpbs incubate room temperature 20 min afterward cell wash addition 1.5 ml pb resuspend 100 08l 0.1 triton x1005 bovine serum albuminpbs contain 3 08m dapi antirabbit igg hl fab 2 fragment alexa fluor 647 conjugate 4414 cell signal technology danvers usa 1:1,000 dilution 15min incubation room temperature dark sample wash add 1.5 ml pb follow another wash 1.5 ml pb cell pellet resuspend 25 08l pb minimum 5,000 event focus collect per sample use image flow cytometer amnis imagestream x mk ii luminex corporation austin tx usa translocation p65 evaluate use builtin protocol nuclear localization idea image channel ch06 ch07 ch11 use brightfield nuclear image dapi translocate probe p65 respectively gate strategy event focus nuclear image normalize frequency v gradient rmsm07ch07 follow gate single cell aspect ratiom06 v aream06 dapi p65 doublepositive event intensitymcch11 v intensitymcch07 event select obtain proportion cell translocate nfκb nucleus normalize frequency v similaritymorphology m07 ch07ch11ch07 data mean ± sem three independent experiment immunoblotting perform describe previously sample mec1 mec1 ver cell prepare culture 24 ml cell 1 × 10 cellsml growth medium supplement 2 heatinactivated fetal bovine serum overnight cell use define level protein basal stimulate condition sample primary cll cell prepare culture 24 ml cell 2 × 10 cellsml growth medium supplement 2 heatinactivated fetal bovine serum cell centrifuge 400× g 5 min 4 °c wash 1 ml cold pb 400× g 5 min 4 °c lysed 100 08l modify ripa buffer 50 mm trishcl 150 mm nacl 0.5 sodium deoxycholate 1 mm edta 1 nonidet p40 ph 7.4 contain 1 08l halt protease inhibitor cocktail 100x cat n° 87785 thermo fisher scientific waltham usa 1 08l halt phosphatase inhibitor cocktail 100x cat n° 78420 thermo fisher scientific waltham usa freeze 80 °c protein isolate cell first thaw sample ice sample sonicated twice 8 vortexed centrifuge 10,000× g 20 min 4 °c supernatant collect total protein concentration determine use dc method sdspage use separation protein sample mix 33 sample load buffer 10 glycerol 0.1 bromophenol blue 3 sodium dodecyl sulfate sd 5 2mercaptoethanol incubate 95 °c 5 min cool ice 25 08g protein separate 10 gel use trisglycine electrophoresis buffer 25 mm trisbase 192 mm glycine 0.1 sd ph 8.3 constant voltage 110 v 90 min afterward protein blot 0.4 08m nitrocellulose membrane use icecold transfer buffer 20 methanol 25 mm trisbase 192 mm glycine 0.1 sd ph 8.3 constant voltage 100 v 60 min membrane block 5 milktrisbuffered saline tb 25 mm trisbase 137 mm nacl 3 mm kcl ph 7.4 0.1 tween 20 ttbs 1 h wash ttbs 3× 5 min incubate primary antibody 1:1,000 dilution 5 bovine serum albuminttbs overnight 4 °c membrane wash ttbs 5× 5 min incubate appropriate secondary antibody 1:10,000 dilution 5 bovine serum albuminttbs 1 h room temperature follow final wash 200500 08l supersignal west femto maximum sensitivity substrate cat n° 34095 thermo fisher scientific pierce il usa add membrane chemiluminescence measure chemiluminescence image system uvitec cambridge alliance 9.7 uvitec lodi nj usa load control membrane strip 62.5 mm trishcl 2 sd 100 mm 2mercaptoethanol ph 6.8 30 min 50 °c reprobed antibody βactin 1:5,000 dilution a5316 sigmaaldrich st. louis mo usa αβtubulin 1:1,000 dilution 2148 cell signal technology danvers usa gapdh 1:1000 dilution 97166 cell signal technology danvers usa primary antibody p38 9212 pp38 mapk thr180tyr182 9215 jnk 9252 pjnk thr183tyr185 9251 mek12 8727 pmek12 ser217221 9154 perk12 thr202tyr204 9101 creb 9197 pcreb ser133 9191 bcl2 15071 pbcl2 2827 bclxl 2764 bid 2002 puma 12450 bax 2772 bak 12105 mcl1 94296 cell signal technology danvers usa antibody cyclin d1 sc718 erk1 sc93 erk2 sc154 1:5,000 santa cruz biotechnology dallas tx usa secondary antibody horse antimouse igg hrplinked antibody 7076 cell signal technology danvers usa goat antirabbit igg antibody hrpconjugate 12348 emd millipore burlington usa data mean ± sem ≥ two independent experiment full uncropped immunoblots present supplemental file ass catalytic activity β1i lmp2 β2β2i β2mecl1 β5i lmp7 follow substrate use acproalaleuamc acpalamc 25 08m south bay bio san jose ca usa acrlramc 50 08m cayman chemical ann arbor mi usa acalaasntrpamc acanwamc 25 08m south bay bio san jose ca usa respectively level nonspecific hydrolysis substrate determine use selective inhibitor 1000 nm ml604440 lmp2 100 nm m3258 lmp7 1000 nm marizomib panproteasome inhibitor β2β2i β2mecl1 residual activity 10 mec1 cell patientderived cll cell 1 × 10 cellsml 4 ml treat 0.1 dmso 100 ngml ifnγ indicate cell centrifuge 300× g 5 min wash 1 ml pb 300× g 5 min cell pellet lysed 100 08l lysis buffer 50 mm trishcl 0.5 mm edta ph 8.0. isolation protein determination total protein concentration perform describe follow addition 10 08l wholecell lysate 80 08l assay buffer 5 mm dithiothreitol 2 mm adenosine 5'triphosphate 50 mm trishcl 0.5 mm edta ph 8.0 without appropriate inhibitor well black 96well plate sample incubate 30 min 37 °c 10 08l substrate prepare assay buffer add release amc measure 1 h 1min interval use microplate reader synergy htx multimode microplate reader biotek instrument inc. winooski vt usa excitationemission filter 360460 nm fluorescence intensity use calculate relative enzyme activity use follow equation ii i. data normalize total protein concentration data mean ± sem ≥ three independent experiment carry duplicate wholeexome sequence mec1 mec1 ver cell perform ng lab constance eurofins genomics europe sequence gmbh constance germany use genome sequencer illumina novaseq sequence mode novaseq 6000 s4 pe150 xp data register bioproject id prjna873921 biosample id sub11975361 accession samn30508221 samn30508222 mec1 mec1 ver sample respectively data obtain flow cytometer process use flowjo version 10.7.2 software data obtain image flow cytometer process use idea version 6.2 software data presentation statistical analysis perform graphpad prism 9.2.0 use follow statistical test student ttest twosided oneway anova twoway anova statistical significance p 0.05 denote significant n asterisk denote p 0.05 p 0.01 p 0.001 p 0.0001 \<SEP>0